Field Robert Stuart 4

What Happened
Robert S. Field, a director of Humana Inc. (HUM), was granted 852 restricted stock units (RSUs) on 2026-05-01. The Form 4 reports the award at $0.00 per share (standard for grants); a footnote states this initial director award is valued at $200,000. The RSUs represent a contingent right to receive one share of Humana common stock per unit.

Key Details

• Transaction date: 2026-05-01; reported on Form 4 filed 2026-05-05. Filing appears timely (Form 4 is generally due within two business days).
• Transaction type/code: Award/Grant (A). Reported price: $0.00 (grant). Units: 852 RSUs.
• Reported value: Footnote indicates an initial award worth $200,000.
• Shares owned after transaction: Not specified in the provided filing.
• Notable footnotes: (F1) RSUs are a contingent right to one share each and are exempt under Rule 16b-3(d)(1) & (3). (F2) Award is part of the annual Director Compensation Program and will be forfeited in full if service is less than one year.

Context
RSUs are a form of deferred compensation: they do not represent immediate share purchases or sales and typically convert to common stock (or are settled in cash) after vesting conditions are met. Grants to directors are common and are often routine compensation rather than a direct signal of insider market sentiment. The forfeiture condition means the award depends on continued service for one year.